Career News – August 9, 2022
View this email in your browser Career News – August 9, 2022 Alexion Director, CMC Team Lead New Haven Associate Director, Biostatistics New Haven +72 more Arvinas ...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
View this email in your browser Career News – August 9, 2022 Alexion Director, CMC Team Lead New Haven Associate Director, Biostatistics New Haven +72 more Arvinas ...
EvolveImmune Therapeutics has appointed Jay S. Fine, Ph.D., as the company’s President of Research and Development. Dr. Fine is an accomplished biopharmaceutical executive with a successful...
MediSynergics reports positive ongoing preclinical development of “ketamine derivative” compounds MS-168 and MS-227 in pain, anxiety, behavior acute toxicity pharmacology, in vitro ADME, and structural elucidation...
Alexion, AstraZeneca’s Rare Disease group, has announced plans to expand in New Haven by leasing space at the new bioscience tower currently under construction at...
View this email in your browser Weekly Roundup – August 4, 2022 Monday Arvinas announced John Northcott would join their team as the new Chief Commercial Officer. “I...
The Blavatnik Fellowship fifth cohort includes Emmanuel Aisabokhae, RPh, MBAv, Ashoka Madduri, PhD, MBA, and Yi Wang, PhD, MBA, who were selected from an extensive group of applicants...
Pfizer has raised the stakes of the COVID-19 vaccine business. The company has launched a midstage trial of the first in a planned series of next-generation,...
The development compound QXT-101 from Qx Therapeutics has been granted fast-track designation by the FDA for the treatment of Pulmonary Graft Dysfunction (PGD) following lung...
Modifi Biosciences reports that the journal Science has published a critical study validating the company’s novel oncology platform based on new classes of molecules that exploit tumor-associated DNA...
Enko reports $70 million in Series C funding, bringing the company’s overall capital raised to date to $140 million. Mystic-based Enko will use the new funds...